McArdle SE - Search Results

1

Anti-tumour therapeutic efficacy of OX40L in murine tumour model.

Ali SA, Ahmad M, Lynam J, McLean CS, Entwisle C, Loudon P, Choolun E, McArdle SE, Li G, Mian S, Rees RC. Ali SA, et al. Among authors: mcardle se. Vaccine. 2004 Sep 9;22(27-28):3585-94. doi: 10.1016/j.vaccine.2004.03.041. Vaccine. 2004. PMID: 15315837 Free article.

2

Induction of human cytotoxic T lymphocytes that preferentially recognise tumour cells bearing a conformational p53 mutant.

McArdle SE, Rees RC, Mulcahy KA, Saba J, McIntyre CA, Murray AK. McArdle SE, et al. Cancer Immunol Immunother. 2000 Oct;49(8):417-25. doi: 10.1007/s002620000137. Cancer Immunol Immunother. 2000. PMID: 11043848

3

Disabled infectious single cycle-herpes simplex virus (DISC-HSV) as a vector for immunogene therapy of cancer.

Rees RC, McArdle S, Mian S, Li G, Ahmad M, Parkinson R, Ali SA. Rees RC, et al. Curr Opin Mol Ther. 2002 Feb;4(1):49-53. Curr Opin Mol Ther. 2002. PMID: 11883695 Review.

4

Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity.

Ali SA, Lynam J, McLean CS, Entwisle C, Loudon P, Rojas JM, McArdle SE, Li G, Mian S, Rees RC. Ali SA, et al. Among authors: mcardle se. J Immunol. 2002 Apr 1;168(7):3512-9. doi: 10.4049/jimmunol.168.7.3512. J Immunol. 2002. PMID: 11907113

5

Phenotypic and functional differences of dendritic cells generated under different in vitro conditions.

McArdle SE, Ali SA, Li G, Mian S, Rees RC. McArdle SE, et al. Methods Mol Med. 2003;81:359-75. doi: 10.1385/1-59259-372-0:359. Methods Mol Med. 2003. PMID: 12725131 No abstract available.

6

Disabled infectious single cycle herpes simplex virus (DISC-HSV) is a candidate vector system for gene delivery/expression of GM-CSF in human prostate cancer therapy.

Parkinson RJ, Mian S, Bishop MC, Gray T, Li G, McArdle SE, Ali S, Rees RC. Parkinson RJ, et al. Among authors: mcardle se. Prostate. 2003 Jun 15;56(1):65-73. doi: 10.1002/pros.10207. Prostate. 2003. PMID: 12746848

7

A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in vitro conditions.

Mian S, Ball G, Hornbuckle J, Holding F, Carmichael J, Ellis I, Ali S, Li G, McArdle S, Creaser C, Rees R. Mian S, et al. Proteomics. 2003 Sep;3(9):1725-37. doi: 10.1002/pmic.200300526. Proteomics. 2003. PMID: 12973733

8

Peptide immunisation of HLA-DR-transgenic mice permits the identification of a novel HLA-DRbeta1*0101- and HLA-DRbeta1*0401-restricted epitope from p53.

Rojas JM, McArdle SE, Horton RB, Bell M, Mian S, Li G, Ali SA, Rees RC. Rojas JM, et al. Among authors: mcardle se. Cancer Immunol Immunother. 2005 Mar;54(3):243-53. doi: 10.1007/s00262-004-0596-7. Epub 2004 Sep 21. Cancer Immunol Immunother. 2005. PMID: 15449037

9

Regulation of CTL responses to MHC-restricted class I peptide of the gp70 tumour antigen by splenic parenchymal CD4+ T cells in mice failing immunotherapy with DISC-mGM-CSF.

Ahmad M, Rees RC, McArdle SE, Li G, Mian S, Entwisle C, Loudon P, Ali SA. Ahmad M, et al. Among authors: mcardle se. Int J Cancer. 2005 Jul 20;115(6):951-9. doi: 10.1002/ijc.20976. Int J Cancer. 2005. PMID: 15723299 Free article.

10

Immunity to tumour antigens.

Li G, Ali SA, McArdle SE, Mian S, Ahmad M, Miles A, Rees RC. Li G, et al. Among authors: mcardle se. Curr Pharm Des. 2005;11(27):3501-9. doi: 10.2174/138161205774414583. Curr Pharm Des. 2005. PMID: 16248804 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page